Opportunity
DIBBS #SPE2DP-26-T-5291
DLA solicitation for 67 bottles of moxifloxacin hydrochloride tablets
Posted
September 29, 2026
Respond By
October 05, 2026
Identifier
SPE2DP-26-T-5291
NAICS
424210, 325412
DLA Troop Support is seeking bottles of prescription moxifloxacin hydrochloride tablets for its Medical Supply Chain Pharm FSA. - Government buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharm FSA; procurement contact: Vanesa M Carbo Acevedo. - Product requested: 67 bottles of moxifloxacin hydrochloride, 400 mg tablets, 30 tablets per bottle; NSN 6505-01-503-4772. The total spans seven requisitions, with quantities of 4, 24, 1, 1, 25, 2, and 10 bottles. - Named approved-source manufacturers/OEMs: TEVA Pharmaceuticals USA, Inc. (NDC00093-7387-56) and Rising Pharma Holdings, Inc. (NDC57237-0156-30). - Notable requirements: FDA-regulated product; 36-month non-extendable shelf life; store at controlled room temperature and protect from high humidity. Delivery is required within 5 days after order.
Description
MOXIFLOXACIN HYDROC (QTY: 4, NSN: 6505-01-503-4772, Purchase Request: 7007458174) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 1, NSN: 6505-01-503-4772, Purchase Request: 7018517863) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 10, NSN: 6505-01-503-4772, Purchase Request: 7007423083) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 24, NSN: 6505-01-503-4772, Purchase Request: 7006831542) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 25, NSN: 6505-01-503-4772, Purchase Request: 7018536597) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 2, NSN: 6505-01-503-4772, Purchase Request: 7006032424) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 1, NSN: 6505-01-503-4772, Purchase Request: 7018540426) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.